Lumentum's $5 Billion Order Book Is Not the Problem — Wall Street's Split on Marvell Is

Two days, two brokerage notes, two very different conclusions about the same stock. That is the backdrop against which Lumentum investors are now being asked to weigh a business with more than $5 billion in committed orders against a merger whose value moves with every tick in Marvell's share price.

Bernstein on Wednesday lifted its price target on Lumentum from $635 to $700 while keeping an "Outperform" rating, according to media reports. The call was seen as the immediate trigger for a rally that was already being helped along by a broader recovery in AI-linked equities and a firmer optical sector. Lumentum, the reports noted, was also clawing back ground lost in the selling that followed news of the Marvell takeover.

UBS took the opposite tack a day earlier, cutting its target from $960 to $686 and sticking with "Neutral," citing execution risk on the transaction. The gap between the two houses is less about Lumentum's order book than about how much faith to place in a deal that has been announced but not completed.

What the Deal Actually Says

Under the agreed terms, Lumentum shareholders would receive 4.5 Marvell shares for each share they own — an all-stock structure. The companies put the implied enterprise value of Lumentum at $115 billion. Because no cash changes hands, the consideration shareholders eventually receive depends entirely on where Marvell trades when the deal closes, which is precisely the uncertainty UBS flagged.

The transaction sits alongside a demand story that Lumentum has been building out in public. Chief executive Michael Hurlston used a CNBC interview on 6 November to explain how the shift from electrical to optical technology is driving the company's growth.

The Numbers Behind the Bull Case

For its first fiscal quarter of 2027, Lumentum reported revenue of $1.26 billion and non-GAAP diluted earnings per share of $4.57. Those are the hard figures on which the AI-investment debate can be pinned down.

Management's guidance for the second fiscal quarter of 2027 points to revenue of between $1.575 billion and $1.63 billion. The company also disclosed purchase commitments exceeding $5 billion tied to its second major NPO/CPO win — a firmer basis for the demand outlook than general growth expectations, since it represents customers contractually committing to buy.

Policy Risk Cuts Across the Sector

Sentiment can shift faster than order books. Media reports said Lumentum and Applied Optoelectronics both slipped after Microsoft objected to a proposed FCC restriction on Chinese optical networking equipment used in AI data centers. The episode put the potential fallout from regulation on optical suppliers squarely in view, and it remains part of how investors price the business for as long as the impact of such interventions is contested.

Weighing on the stock more recently was the resignation of Nvidia chief Jensen Huang, which, as AP reported, pressured AI-oriented technology names and the broader indices. The concern underneath is whether profits from artificial intelligence will justify the scale of the spending behind it.

That is the tension running through the Lumentum story: a company can point to real revenue and signed commitments, yet its market value still hinges on how much confidence investors are willing to extend to the entire investment cycle. For now, the purchase commitments and the revenue guidance make the case. Whether the market finds that case persuasive will depend on whether the business delivers.